NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization
Clinical and Translational Medicine · 2024-03 · 14 (3)
DOI: 10.1002/ctm2.1621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 11.03.2024. Verfasst von Shaomin Zou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Methyltransferases. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Special Young Talent Plan of Scientific and Technological Innovation.
Abstract (Originalsprache)
Background
NOP2/Sun domain 2 (NSUN2) is one of the important RNA methyltransferases catalyzing 5‐methylcytosine (m5C) formation and participates in many critical bioprocesses. However, the roles and underlying molecular mechanisms of NSUN2‐mediated m5C modification in colorectal cancer (CRC) remain unclear.
Methods
To explore the NSUN2 expression in CRC, fresh tissue samples were collected and Nsun2 knockout mouse was constructed. In vitro and in vivo functional assays were conducted to assess the role of NSUN2. RNA array and bisulfite sequencing were used to investigate the potential targets. The mechanisms of NSUN2 function on SKIL were identified by m5C‐methylated‐RNA immunoprecipitation and RNA stability assays. Additionally, tissue microarray analysis was conducted and patient‐derived tumour xenograft mouse (PDX) models were used to define the potential therapeutic targets.
Results
NSUN2 was highly expressed in CRC and correlated with poor CRC patient survival. Moreover, silencing NSUN2 suppressed CRC tumourigenesis and progression in Nsun2 knockout mouse models. In vitro and in vivo studies suggested that NSUN2 promoted colorectal cancer cell growth. Mechanistically, SKI‐like proto‐oncogene (SKIL) is positively regulated by NSUN2, and the NSUN2‐SKIL axis is clinically relevant to CRC. NSUN2 induced m5C modification of SKIL and stabilized its mRNA, which was mediated by Y‐box binding protein 1 (YBX1). Elevated SKIL levels increased transcriptional coactivator with PDZ‐binding motif (TAZ) activation.
Conclusions
Our findings highlight the importance of NSUN2 in the initiation and progression of CRC via m5C‐YBX1‐dependent stabilization of the SKIL transcript, providing a promising targeted therapeutic strategy for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
- Jiménez Díaz Foundation University Hospital, Madrid, Spain.
ORCID-Profile: Weiyao Li, Lekun Fang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangdong Special Young Talent Plan of Scientific and Technological Innovation
- Natural Science Foundation of Guangdong
- Guangzhou Basic Research Foundation
- National Key Clinical Discipline
- National Key Research and Development Program of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zou, S., Huang, Y., Yang, Z., Zhang, J., Meng, M., Zhang, Y., Feng, J., Sun, R., Li, W., Wang, W., López, J. G., & Fang, L. (2024). NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clinical and Translational Medicine, 14(3). https://doi.org/10.1002/ctm2.1621
Vancouver
Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clinical and Translational Medicine. 2024;14(3). doi:10.1002/ctm2.1621
BibTeX
@article{Zou2024,
author = {Zou, Shaomin and Huang, Yizhi and Yang, Ziqing and Zhang, Jieping and Meng, Manqi and Zhang, Yijing and Feng, Junyan and Sun, Rui and Li, Weiyao and Wang, Wencong and López, Jesús García-Foncillas and Fang, Lekun},
title = {NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {3},
doi = {10.1002/ctm2.1621}
}
EUVIMED